Alexis Carter, MD

Pathology Informaticist and Molecular Pathologist. Diplomate in AP/CP, MGP and Clinical Informatics. My opinions are my own. Following does not mean endorsing.

[Association for Molecular Pathology @AMPath]

We will be hosting a series of broadcasts about essential bioinformatics roles, responsibilities and competencies for professionals in clinical molecular diagnostic laboratories, based on a 2025 collection of papers published in @JMDiagn.

Learn more: https://t.co/kjQibdJgo3

[Alexis Carter, MD @PathByteChic]

How can 🩸 + 🤖 = 😬 ? Find out in this episode!
@HSLuu_Pathology

[CAPathologists @Pathologists]

New CIPI Connections episode: Alexis Carter, MD, FCAP, and Richard Davis, MD, MPH, BS, FCAP, investigate the mysterious case of a disappearing hypereosinophilic syndrome. Listen now: https://t.co/4eFLOSpiDg

[Alexis Carter, MD @PathByteChic]

New episode in the @Pathologists CIPI Connections podcast!

https://t.co/ZylIDOVCVt

[Alexis Carter, MD @PathByteChic]

Trouble with blood product orders? Physicians ordering transfusions and transfusion medicine services should read this paper:
Standardization of Blood Product Orders Improves Patient Safety in Pediatric Transfusion Medicine: A Collaborative Project https://t.co/UNfaFqnUm5

[Amy Diehl, Ph.D. @amydiehl]

In a study of professors, women got 378 new work requests over 4 wks vs 118 for men. Women spent more time on service, advising & teaching; men on research. Orgs should track who is taking extra duties & ensure they are rewarded and distributed fairly. https://t.co/l1HTN5biwP

[Alexis Carter, MD @PathByteChic]

Happy to announce part 3 in the series on what genomic bioinformaticists working in clinical settings need to know.

https://t.co/ydvW5TPhBL

[Association for Molecular Pathology @AMPath]

We convened an expert working group to update the guideline for 🧬classification, annotation, interpretation and reporting of somatic sequence variants🧬 (originally published in 2017).

The working group is seeking comments on its draft recommendations: https://t.co/2o7eM0e7e9.

[Alexis Carter, MD @PathByteChic]

Dr. Doc de Baca giving the opening address to the preparation for AI long course going on now in Bandol ⁦@Pathologists⁩ #CAP2024 #CAP24

[Alexis Carter, MD @PathByteChic]

Awesome mindfulness and heartfulness session with ⁦@Vidyasath⁩ at #cap24 #cap2024 ⁦@Pathologists⁩

[Alexis Carter, MD @PathByteChic]

I have finally discovered #RegEx for parsing genomic variants out of text. Today is a happy day. I love being a nerd. That is all.

[The Journal of Molecular Diagnostics @JMDiagn]

Congratulations to @JMDiagn Editor in Chief Dr. Ron Przygodzki on winning the 2024 Jeffrey A. Kant Leadership Award, which is @AMPath's highest honor, given for exceptional leadership in advancing the mission and goals of the Association for Molecular Pathology.

@gizbab

[Eve Propper @EvePropper]

Very sad new for the International Pathology Community of a legend. Vale Dr Christopher Fletcher.

[Toby C. Cornish MD, PhD @TobyCornish]

Finally made it to "the mothership" for a bit of training! There are several familiar names online as well @pathbytes @PathByteChic @ctlin1

[Alexis Carter, MD @PathByteChic]

@TobyCornish @pathbytes @ctlin1 Hey I didn’t know you were in class!!

[Somak Roy, MD @roysomak4]

It was a super exciting to be on the podcast “talk python to me” and discuss how python is used in genomics, molecular pathology, and patient care!! Thank you @mkennedy for having me on your show. @Aparwani_dpath @PathPro @AMPath @PathByteChic https://t.co/VJSjU13ZR7

[Federico Monzon @GenomicPath]

Just a few more days for #AMPEurope2024!! Looking forward to an amazing conference. @AMPath #moleculardiagnostics #genomics #molecularpathology #biomarkers #precisionmedicine

[Alexis Carter, MD @PathByteChic]

...and I've heard this hundreds of times from different laboratory and radiology device manufacturers

[Alexis Carter, MD @PathByteChic]

This AM: Per vendor of @US_FDA-cleared device with VERY outdated software: 1) FDA approval severely slows necessary upgrades in US vs. non-US market 2) can't patch components because components affecting test system incompatible with patches. @AMPath @AMIAinformatics @pathbytes

[Alexis Carter, MD @PathByteChic]

@AlannaChurch_MD Aw, where are the mitotic figures? :-)